#UroOnc
LightNews LightNews
achoud72.bsky.social
We're recruiting! Want to join a vibrant #UroOnc team? Learn all about clinical trials? Do some research? Then get in touch 😃 @oncoalert.bsky.social @oncocook.bsky.social @yeepei.bsky.social @ukecrc.bsky.social @oncologyforum.bsky.social
👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽
www.healthjobsuk.com/job/v6962786
Job vacancy: Clinical Research Fellow in Uro-Oncology, The Christie NHS Foundation Trust, Manchester | trac.jobs
www.healthjobsuk.com
January 24, 2025 at 5:52 PM
vjoncology.bsky.social
Missed out on #GU25?

Listen to our latest podcast, and to a preview below, where
@prof-nick-james.bsky.social discusses updates from the STAMPEDE trial, and the benefits of transdermal estradiol patches in #prostatecancer!

#kcsm #uroonc #blcsm #pcsm @icr.ac.uk @ascocancer.bsky.social
February 21, 2025 at 10:12 AM
vjoncology.bsky.social
Had the pleasure to speak with @erplimackmd.bsky.social of Fox Chase Cancer Center at #GU25 on:

⭐OS results of CheckMate 274
⭐Additional NIAGARA findings
⭐RETAIN-2 of a risk-adapted approach for MIBC
⭐Phase I/II study of nivo and axitinib in RCC

#blcsm #kcsm #tscsm #uroonc @ascocancer.bsky.social
February 15, 2025 at 6:35 PM
vjoncology.bsky.social
🎥@ehbent.bsky.social of @mskcancercenter.bsky.social explores how biomarkers may guide use of metastasis-directed radiation ± hormonal therapy in oligometastatic prostate cancer, though clinical traits still lead.

Watch ➡️ buff.ly/pkhx0zl

@ascocancer.bsky.social #ASCO25 #UroOnc #UroSoMe #PCSM
July 12, 2025 at 5:00 PM
vjoncology.bsky.social
Had the pleasure to catch up with @prof-nick-james.bsky.social of @icr.ac.uk talks on the STAMPEDE trial, which assessed tE2 patches in #prostatecancer, and the RAD-IO trial of durvalumab & chemo-RT in #bladdercancer

Visit VJOncology.com for more!

@ascocancer.bsky.social #GU25 #pcsm #blcsm #uroonc
February 13, 2025 at 9:04 PM
vjoncology.bsky.social
It was great to speak with Roger Li of @moffittnews.bsky.social on how ctDNA can improve staging of upper tract bladder cancer, and updates in BCG unresponsive NMIBC at #GU25.

Keep an eye out on our page for more interviews throughout the day!

@ascocancer.bsky.social #blcsm #uroonc
Roger Li being interviewed by VJOncology
February 13, 2025 at 5:51 PM
erneurogen.bsky.social
At #EAU25, John Osborne shared updates on the penile cancer patient survey.
🗣️ Penile cancer patient? Share your voice: bit.ly/41QeQhz
Key needs: faster diagnosis, better post-op support.
#PenileCancer #EU4Health #UroOnc #EUCancerPlan
March 24, 2025 at 2:00 PM
erneurogen.bsky.social
It’s #UrologyWeek! 🚻 Cancer patients face higher infection risks during treatment & recovery. Preventing & managing UTIs is critical to outcomes. 🔬

🔗 eurogen-ern.eu/urology-week...

#EUfunded #EU4Health #UroOnc #EUCancerPlan #EUCancerMission #RareDisease #ERNs
September 25, 2025 at 8:14 AM
jco-asco.bsky.social
Why it matters for #bladdercancer care: better risk-adapted bladder-sparing strategies, smarter use of biomarkers in decision-making, and trials built around what matters most to patients & survivors. #uroonc #MIBC
December 15, 2025 at 8:22 PM
peerview.bsky.social
Modern #ProstateCancer therapy: Dr. Morgans, Smith, and Srinivas discuss the latest efficacy and safety data and strategies for individualizing patient care throughout the disease continuum. Produced with ZEROprostate.org bit.ly/3C26qe1 #UroOnc #medonc #medsky
MDADI
MDADI
bit.ly
April 7, 2025 at 7:36 PM
vjoncology.bsky.social
🎥Aslı Doğa Munzur, BSc, discusses clonal hematopoiesis (CH) as a potential biomarker in #mCRPC

⭐Ongoing work aims to define CH’s role in predicting blood disorder risk & guiding patient selection:

➡️https://buff.ly/Y9FKoJW

@ascocancer.bsky.social #ASCO25 #UroOnc #UroSoMe #PCSM
Clonal hematopoiesis monitoring as a future biomarker in mCRPC - VJOncology
Aslı Doğa Munzur, BSc, Vancouver Prostate Centre, Vancouver, Canada, speaks on the potential of clonal hematopoiesis (CH) as a biomarker...
buff.ly
October 10, 2025 at 2:54 PM
urogoldjournal.bsky.social
A patient with clinical stage IA pure seminoma was managed with surveillance and participated in a study on miR-371a-3p and miR-372-3p as potential serum biomarkers. https://is.gd/cKGnOX @UroOnc
December 29, 2025 at 1:50 PM
erneurogen.bsky.social
🧬 Discover how microRNAs can improve diagnosis & monitoring of testicular cancer!

📅 Wed 4 Feb @ 18:00 CET

🎙 João Lobo shares translational research & clinical insights

🔗 Register: events.zoom.us/ev/ArCdYFymJ...

#EUfunded #UroOnc #RareDisease #ERNs @ec.europa.eu @jardinjointaction.bsky.social
February 4, 2026 at 9:14 AM
erneurogen.bsky.social
🧬 Discover how microRNAs can improve diagnosis & monitoring of testicular cancer!

📅 Wed 4 Feb @ 18:00 CET

🎙 João Lobo shares translational research & clinical insights

🔗 Register: events.zoom.us/ev/ArCdYFymJ...

#EUfunded #UroOnc #RareDisease #ERNs @ec.europa.eu @jardinjointaction.bsky.social
February 2, 2026 at 9:14 AM
erneurogen.bsky.social
🚨 Join @erneurogen.bsky.social for an expert-led webinar on Adrenal Cancer & Malignant Cysts

📅 Tonight @ 18:00 CET
🎙️ Hans Langenhuijsen & Nikola Knežević
🎓 EACCME accredited (live attendees)

🔗 events.zoom.us/ev/AuzZaVXQf...

#EUfunded #UroOnc #ERNs #RareDisease @jardinjointaction.bsky.social
January 28, 2026 at 9:14 AM
erneurogen.bsky.social
🧠 Join @erneurogen.bsky.social for an expert-led webinar on Adrenal Cancer & Malignant Cysts

📅 Wed 28 Jan @ 18:00 CET
🎙️ Hans Langenhuijsen & Nikola Knežević
🎓 EACCME accredited (live attendees)

🔗 events.zoom.us/ev/AuzZaVXQf...

#EUfunded #UroOnc #ERNs #RareDisease @jardinjointaction.bsky.social
January 26, 2026 at 9:14 AM
ucsfurology.bsky.social
Save-the-Date!
UroOnc Fellowship Virtual Open House

✨Learn more about our program with the opportunity to speak with our PDs and meet our current fellows!

📆Tuesday, 1/21/2025
⏰5:00-5:45PM PST
✍️Register here: tiny.ucsf.edu/UCSFUroOnc12...
January 8, 2025 at 8:52 PM
erneurogen.bsky.social
🧬 Missed our webinar on microRNA studies in testicular germ cell tumours?

📺 Watch now: youtu.be/ezg8w7SkOw8

📰 Subscribe: tinyurl.com/ERNeUROGENne...

#EUfunded #EU4Health #RareDisease #ERNs #UroOnc #EUCancerPlan #EUCancerMission #UroSoMe
@ec.europa.eu @jardinjointaction.bsky.social
ERN eUROGEN Webinar 140: Applicability of microRNA studies in testicular germ cell tumours
YouTube video by ERN eUROGEN
youtu.be
February 9, 2026 at 2:20 PM
vjoncology.bsky.social
We’re live in San Francisco covering the latest in #genitourinarycancer at #GU25 🌉

Keep an eye out for who we’ll be interviewing over the next few days and visit VJOnocology.com for exclusive videos, podcasts, and more!

@ascocancer.bsky.social #pcsm #blcsm #kcsm #tscsm #uroonc
February 13, 2025 at 5:17 PM
erneurogen.bsky.social
Join us for a cutting-edge webinar on Stage II Testicular Germ Cell Tumours 💥

👨‍⚕️Dr Arnout Alberts shares the latest in personalised, multidisciplinary care
📅 Wed 1 Oct @ 17:00 CEST
🎓 EACCME-accredited
🔗 bit.ly/eUROGEN01Oct25

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #UroOnc #UroSoMe
September 25, 2025 at 9:38 AM
erneurogen.bsky.social
🚨 TONIGHT! Join us for a cutting-edge webinar on Stage II Testicular Germ Cell Tumours

👨‍⚕️Dr Arnout Alberts shares the latest in personalised, multidisciplinary care
📅 Wed 1 Oct @ 17:00 CEST
🎓 EACCME-accredited
🔗 bit.ly/eUROGEN01Oct25

#EUfunded #EU4Health #RareDisease #ERNs #UroOnc #UroSoMe
October 1, 2025 at 8:14 AM
vjoncology.bsky.social
🎥 Cristina Suárez (@vhio.bsky.social) discusses CONTACT-03 subgroup analysis on cabozantinib ± atezolizumab in advanced #RCC post-immunotherapy at #ASCO25. Key insights for treatment sequencing strategies.

🔗 buff.ly/uix2tBW

@ascocancer.bsky.social #KidneyCancer #RCC #GUsm #UroOnc #UroSoMe
CONTACT-03: subgroup analysis of 2L cabozantinib ± atezolizumab in aRCC - VJOncology
Cristina Suárez, MD, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain, discusses a subgroup analysis from the CONTACT-03 study (NCT04338269)...
buff.ly
August 25, 2025 at 5:15 PM
vjoncology.bsky.social
⭐ Yue Che, MD, shares RAISN trial: ICG-guided sentinel node biopsy is feasible & well tolerated in stage I testicular cancer, aiming to reduce chemo use:

🎥 buff.ly/kF09jHH

#EAU25 #UroOnc #UroSoMe #CTSM #TrialUpdate #TSCsm
RAISN: indocyanine green-guided lymph node dissection in testicular cancer - VJOncology
Yue Che, MD, University Hospital of Duesseldorf, Düsseldorf, Germany, discusses the evolving role of retroperitoneal lymph node dissection and therapy...
buff.ly
October 1, 2025 at 2:54 PM
vjoncology.bsky.social
🎥Andrew Parsonson of Macquarie University shares updated Phase I/II results for B7H3-targeting ADC DB-1311 in heavily pretreated CRPC

Watch ➡️ buff.ly/gyAysrg

@ascocancer.bsky.social #ASCO25 #PCSM #UroOnc
Phase I/II trial of DB-1311, a B7H3-tageting ADC, in pretreated CRPC - VJOncology
Andrew Ohyama Parsonson, FRACP, MBBS, Macquarie University, Sydney, Australia, discusses updated results from the Phase I/II trial (NCT05914116) of DB-1311,...
ow.ly
July 27, 2025 at 8:01 AM
vjoncology.bsky.social
🎥Results from PDIGREE: ipi + nivo in mccRCC shows consistent safety & early CRs in a diverse U.S. population

@tiansterzhangmd.bsky.social shares insights from #ASCO25

➡️https://buff.ly/o2oUojf⬅️

@ASCO #kcsm #UroOnc #UroSoMe #CTSM #TrialUpdate #ImmunoOnc
Ipilimumab and nivolumab induction in PDIGREE: step 1 findings in mccRCC - VJOncology
Tian Zhang, MD, UT Southwestern Medical Center, Dallas, TX, describes results from step 1 of the PDIGREE trial (NCT03793166), which...
buff.ly
July 22, 2025 at 8:02 AM